BackSage Therapeutics Overview

Sage Therapeutics Receivables

Track Sage Therapeutics's receivables ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00

Peer trimmed avg / median

Loading

Sage Therapeutics Receivables History

Loading

Sage Therapeutics vs. peers: Receivables Comparison

Loading

Sage Therapeutics Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Sage Therapeutics (SAGE) FAQ

Sage Therapeutics posts a receivables of $0 as of June 2025. In the prior-year period, the figure was $0. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Sage Therapeutics's receivables was $0. The latest reading is $0 (period ending June 2025). Use the history and growth charts on this page for a longer lookback.

Receivables is one piece of Sage Therapeutics's financial statement story. At $0, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for SAGE's receivables usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Sage Therapeutics's other metric pages and overview cover the third.

Judging Sage Therapeutics against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in receivables easier to interpret. Start with $0 here, then scan peer and history charts to see if the gap is persistent.